Loading data
PULMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 7.81 m USD | 7.3 m USD | 6.07 m USD | 5.17 m USD |
| Research and development expense | 38 k USD | 7.17 m USD | 15.52 m USD | 18.24 m USD | 15.38 m USD |
| Operating profit | -5.17 m USD | -9.76 m USD | -14.74 m USD | -18.95 m USD | -20.17 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -5.16 m USD | -9.56 m USD | -14.12 m USD | -18.84 m USD | -20.17 m USD |
| Net income attributable to common shareholders | — | — | — | -18.84 m USD | -23.37 m USD |
| Basic earnings per share | -1.41 USD/share | -2.62 USD/share | -3.87 USD/share | -5.46 USD/share | -8.63 USD/share |
| Diluted earnings per share | -1.41 USD/share | -2.62 USD/share | -3.87 USD/share | -5.46 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.